![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » J&J, Pharmacyclics File Breakthrough Drug Ibrutinib
J&J, Pharmacyclics File Breakthrough Drug Ibrutinib
July 11, 2013
Johnson and Johnson and Pharmacyclics have submitted their blood cancer drug ibrutinib to the FDA for marketing approval for two different types of leukemia.
Pharma Times
Pharma Times
Upcoming Events
-
21Oct